Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single center open-label clinical phase I trial (NEON trial)

Data Availability

Combinations of the demographic data could possibly identify participants and thereby compromise participant privacy. Thus, per-patient details on demographics and eligibility criteria cannot be shared. All remaining relevant data are within the manuscript and its Supporting Information files.